Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_assertion type Assertion NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_head.
- NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_assertion description "[This review describes the history of the angiogenic switch illustrated in the literature and with particular reference to the three transgenic mouse models, namely RIP1-TAG2, keratin-14 (K14) (human papilloma virus) HPV16 and papilloma virus, used for stage-specific assessment of the effects of antiangiogenic and antitumorigenic agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_provenance.
- NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_assertion evidence source_evidence_literature NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_provenance.
- NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_assertion SIO_000772 16990761 NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_provenance.
- NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_assertion wasDerivedFrom befree-20140225 NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_provenance.
- NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_assertion wasGeneratedBy ECO_0000203 NP520929.RAz7DGk_1YevUBlU8Mqt02qDfMWAp5tDVtA-orL99Tko0130_provenance.